Callum Jones
A study has found the number of times men should be ejaculating in a month to lower the chance of prostate cancer developing.
One in eight males will develop prostate cancer at some point in their lifetime, according to the American Cancer Society. Meanwhile, it's predicted that 36,320 men will die from prostate cancer in the US this year.
Six in ten men who are diagnosed are 65 or older, while the risk is said to be higher in African American men and in Caribbean men of African ancestry.
Health experts have spoken about ways to reduce the chance of developing the deadly disease, and one of them involves ejaculating a certain number of times per month.
Advert
A study published in European Urology in 2016 followed the sexual activity of close to 32,000 men between 1992 and 2010.
And they discovered that men who ejaculated the most — defined as at least 21 times a month — had a 20 percent lower chance of developing prostate cancer compared to those ejaculating four to seven times in a month.
The survey stated: "We evaluated whether ejaculation frequency throughout adulthood is related to prostate cancer risk in a large US-based study.
"We found that men reporting higher compared to lower ejaculatory frequency in adulthood were less likely to be subsequently diagnosed with prostate cancer.
"These findings provide additional evidence of a beneficial role of more frequent ejaculation throughout adult life in the aetiology of PCa [prostate cancer], particularly for low-risk disease."
Dr. Anne Calvaresi, who is the chair of the Urology Care Foundation’s Prostate Health Committee, added: "This large prospective study provides the strongest evidence to date of a beneficial role of ejaculation in the prevention of prostate cancer."
It remains unclear what exactly is the reason for the sharp decrease, thought Urology Care notes that ejaculation could well flush out the harmful chemicals that build up in semen.
As per Mayo Clinic, symptoms of early prostate cancer include:
There's also different symptoms that present themselves in the advanced stages of prostate cancer, these include: